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Increasing numbers of refugees from Burma (Myan-
mar) are resettling in Western countries. We performed a 
retrospective study of 156 Burmese refugees at an Austra-
lian teaching hospital. Of those tested, Helicobacter pylori 
infection affected 80%, latent tuberculosis 70%, vitamin D 
deﬁ  ciency 37%, and strongyloidiasis 26%. Treating these 
diseases can prevent long-term illness. 
B
urma (Myanmar) has been the most common country 
of origin for refugees who have recently resettled in 
the United States and Australia (1,2). Before resettling in 
Australia, most refugees undergo testing for HIV, have a 
chest radiograph to exclude active tuberculosis (TB), and 
may undergo other testing, depending on exposure risk. 
Many refugees also receive a health check and treatment 
for malaria and stool parasites within 72 hours of departure 
for Australia (3,4). Most refugees who resettle in Victoria, 
Australia, are screened by primary care doctors and then 
referred to specialist clinics as appropriate. 
In this study, we examined the effect of illness and 
the adequacy and completeness of health screening among 
Burmese refugees referred to the infectious diseases clinic 
of an Australian tertiary hospital during a 5-year period.
Methods
We performed a retrospective cohort study of all Bur-
mese refugees who attended the Victorian Infectious Dis-
eases Service outpatient clinics at the Royal Melbourne 
Hospital, Australia, during January 1, 2004–December 
31, 2008. Patients were identiﬁ  ed through the hospital 
registration database, and medical, pathologic, radiolog-
ic, and pharmacologic records were reviewed. Screening 
tests audited included those suggested by the Australasian 
Society for Infectious Diseases refugee screening guide-
lines (5), along with vitamin D and hematologic studies. 
These latter tests included full blood count, mean corpus-
cular volume, and platelet count. Investigations were per-
formed at the discretion of the treating doctor, and not all 
tests were performed for each patient. Time was calculated 
from time of arrival in Australia to ﬁ  rst clinic attendance. 
The results of serologic tests and QuantiFERON-TB Gold 
tests (QFT-G; Cellestis Limited, Carnegie, Victoria, Aus-
tralia), were interpreted according to the manufacturers’ 
recommendations.
Conditions were deﬁ  ned according to prespeciﬁ  ed cri-
teria as follows: schistosomiasis; strongyloidiasis; HIV and 
syphilis (positive serologic test results); hepatitis C virus 
(RNA detected by PCR); Helicobacter pylori (positive re-
sults for fecal antigen test, carbon-14 breath test, or sero-
logic analysis); malaria (thick and thin blood ﬁ  lms or im-
munochromatographic test result positive for Plasmodium 
species); chlamydia and gonorrhea (DNA detected by PCR 
in ﬁ  rst-pass urine); active TB (microbiologic or histologic 
evidence of Mycobacterium tuberculosis infection or re-
ceiving treatment for active TB during the study period); 
latent TB infection (Mantoux test result >10 mm or positive 
QFT-G result and no clinical evidence of active disease); 
chronic hepatitis B virus (HBV; hepatitis B surface anti-
gen detected); isolated core antibody against HBV (hepa-
titis B core antibody detected, hepatitis B surface antibody 
and hepatitis B surface antigen not detected); pathologic 
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stool parasites (stool microscopy positive for a pathogenic 
species); vitamin D deﬁ  ciency (serum 25[OH] vitamin D 
level <50 nmol/L); anemia (hemoglobin level <120g/L); 
and eosinophilia (eosinophil count >0.4 × 109 cells/L). The 
Melbourne Health Human Research Ethics Committee ap-
proved this study as a quality assurance audit.
Results
A total of 156 Burmese refugees were referred to the 
infectious diseases outpatient clinics at the Royal Mel-
bourne Hospital during the study period. Table 1 sum-
marizes the characteristics of these patients. Median age 
was 30 years (range 16–86 years); approximately half were 
male (51%) and of Karen ethnicity (48%). Most refugees 
were born in Burma (97%) and had spent time in a refugee 
camp (97%). The proportion of these patients who were 
screened according to the Australian refugee health guide-
lines is shown in the Figure. More than 90% of study pa-
tients were tested for 6 diseases (Mycobacterium TB, HIV, 
hepatitis B, hepatitis C, schistosomiasis, and Strongyloides 
stercoralis infection).
Table 2 shows the prevalence of selected medical con-
ditions in this patient group. Chronic HBV infection was 
found in 14% of the group; isolated core antibody against 
HBV was found in 13%. Hepatitis B DNA was not detected 
in the serum of any patients with isolated core antibody 
against HBV. One person had HIV infection; this person 
had a chronic infection with HBV. H. pylori infection was 
identiﬁ  ed in 80% of those tested (7 persons by carbon-14 
breath test, 7 by fecal antigen test, and 19 by serologic anal-
ysis). No cases of multidrug-resistant TB were found.
Eosinophilia was documented in 35% of those tested, 
47% of whom had strongyloidiasis, 4% schistosomiasis, and 
24% a pathologic stool parasite, that causes eosinophilia. Eo-
sinophilia was not explained by these conditions in 33%.
Discussion
In recent years, an increasing number of refugees from 
Burma have resettled in Australia, North America, and Eu-
rope. This study reports high rates of H. pylori infection 
(80%), latent TB infection (70%), vitamin D deﬁ  ciency 
(37%), and strongyloidiasis (26%) in Burmese refugees at-
tending the infectious diseases clinics of a Melbourne ter-
tiary referral hospital. 
A Canadian study of 68 Karen refugees, more than half 
of whom were <18 years of age, appears to be the only 
previously published study on the health status of Burmese 
refugees settled in a Western country (6). One unpublished 
study found on the Internet was conducted by the Minne-
sota Department of Health, which examined 159 Burmese 
migrants, but no demographic information was included 
(7). We have compared our screening results with those of 
these 2 studies in Table 2. 
A high rate of parasitic intestinal infections has been 
documented in refugees from Burma in Thailand (8–10) 
and North America (6,7), and our ﬁ  ndings are consistent 
with these studies. Parasitic intestinal infections were com-
mon in our study despite some refugees reporting that they 
had received predeparture drug therapy with albendazole. 
Therefore, we suggest that refugees migrating from Burma 
to Australia who underwent postarrival stool evaluation 
may not have received the predeparture antiparasitic, or if 
received, the treatment was ineffective. Moreover, infec-
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Table 1. Patient characteristics, Burmese refugees in Australia, 
2004–2008*
Characteristic Value
Age group, y, no. (%) 
 <25  36  (23.1) 
 25–49  108  (69.2) 
>50 12 (7.7)
Gender, no. (%) 
 M  80  (51.3) 
 F  76  (48.7) 
Country of birth, no. (%) 
  Burma (Myanmar)  152 (97.4) 
 Thailand  4  (2.6) 
Preferred language, no. (%), n = 155 
 Burmese  23  (14.8) 
 Karen  74  (47.7) 
 Chin  55  (35.5) 
 English  2  (1.3) 
 Zotung  1  (0.6) 
Transit through refugee camp, no. (%), n = 137  133 (97.1) 
Country of refugee camp, no. (%), n = 135 
  Thailand/Thailand-Burma border  71 (52.6) 
 Malaysia  55  (40.7) 
 Other  9  (6.7) 
Referral by general practitioner, no. (%)  151 (96.8) 
No. clinic visits per refugee, median (range)  5 (1–18) 
No. months attended clinic, median (range)  8 (1–23) 
No. months in Australia, median (range)   4 (<1–60) 
*n = 156 unless otherwise specified. 
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Figure. Proportion of 156 recently arrived Burmese refugees 
with documented screening tests for common health conditions, 
Australia, 2004–2008. Most of these tests are recommended by the 
Australasian Infectious Diseases Society guidelines (5). Tests for 
vitamin D levels are beyond the scope of these guidelines. Black, 
tested; red, not tested.Infectious Diseases among Burmese Refugees
tion with S. stercoralis was common in this study. This 
parasite is unlikely to be eradicated with only 1 dose of 
albendazole and is associated with chronic complications, 
including hyperinfection syndrome and death (11).
The rate of infection with H. phylori in this group was 
surprisingly high at 80%, although  the numbers of refugees 
tested was small and those tested were symptomatic. High 
rates of infection with H. phylori have been seen in other 
immigrant groups (12,13). This result reinforces the need 
to question refugees regarding dyspeptic symptoms and to 
test those with symptoms because of established links be-
tween H. pylori infection and iron deﬁ  ciency, peptic ulcer 
disease, and gastric cancer (14,15).
National screening protocols for refugees were closely 
followed in this study for most infectious diseases. Lower 
compliance (<88%) with screening protocols was reported 
for malaria, chlamydia, and gonorrhea. However, these con-
ditions were uncommon in this group. Ongoing education 
of health professionals who care for refugees is required to 
encourage more complete screening of refugees.
This study has a number of limitations. A relatively 
small number of patients were tested. Because this study 
was retrospective and screening was incomplete for some 
patients, certain diseases may be underestimated, or if test-
ing was based on symptoms rather than true screening, 
diseases may be overestimated. Some conditions will be 
overrepresented because of referral bias and because cer-
tain tests (e.g., for H. pylori) were performed as diagnostic 
evaluation of symptomatic patients. This study highlights 
the difﬁ  culties in providing complete health screening for 
refugees, outlines the range of health problems among 
Burmese refugees referred to an adult tertiary hospital in 
Australia, and reinforces the high prevalence of treatable 
conditions in refugee communities.
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